113 related articles for article (PubMed ID: 2934538)
1. Treatment of periodontal disease in beagles with lodoxamide ethyl, an inhibitor of mast cell release.
Jeffcoat MK; Williams RC; Johnson HG; Wechter WJ; Goldhaber P
J Periodontal Res; 1985 Sep; 20(5):532-41. PubMed ID: 2934538
[No Abstract] [Full Text] [Related]
2. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
Johnson HG; Sheridan AQ
Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
[TBL] [Abstract][Full Text] [Related]
3. The development of Wy-41,195, an orally effective antiallergic drug in animal models.
Lewis AJ; Carlson RP; Forster TJ; Chang J; Hand JM; Undem BJ; Buckner CK; Tio C; Sisenwine SF; Daniel WC
Agents Actions; 1986 Jun; 18(3-4):306-12. PubMed ID: 2428218
[No Abstract] [Full Text] [Related]
4. Inhibition of the adverse reaction to diethylcarbamazine in Dirofilaria immitis-infected dogs by lodoxamide ethyl.
Desowitz RS; Palumbo NE; Perri SF; Sylvester MS
Am J Trop Med Hyg; 1982 Mar; 31(2):309-12. PubMed ID: 7072895
[TBL] [Abstract][Full Text] [Related]
5. Lodoxamide for vernal keratoconjunctivitis.
Med Lett Drugs Ther; 1994 Mar; 36(918):26. PubMed ID: 8121328
[No Abstract] [Full Text] [Related]
6. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
Watt GD; Bui TC; Bewtra AK; Townley RG
J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oxidative enzymes by anti-allergy drugs.
White GJ
Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drug.
Case RL; Rogers PB; VanArsdel PP; Altman LC
JAMA; 1982 Feb; 247(5):661-4. PubMed ID: 7033581
[No Abstract] [Full Text] [Related]
9. Effect of iodoxamide ethyl on allergy skin tests.
Frigas E; Reed CE
J Allergy Clin Immunol; 1980 Apr; 65(4):257-62. PubMed ID: 7358942
[TBL] [Abstract][Full Text] [Related]
10. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
[TBL] [Abstract][Full Text] [Related]
11. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
[TBL] [Abstract][Full Text] [Related]
12. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
[TBL] [Abstract][Full Text] [Related]
13. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
Reilly FD; Cilento EV; McCuskey RS
Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
[TBL] [Abstract][Full Text] [Related]
14. The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.
MacKenzie AE; Caltabiano G; Kent TC; Jenkins L; McCallum JE; Hudson BD; Nicklin SA; Fawcett L; Markwick R; Charlton SJ; Milligan G
Mol Pharmacol; 2014 Jan; 85(1):91-104. PubMed ID: 24113750
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
[TBL] [Abstract][Full Text] [Related]
17. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
Parrish RW; Davies BH
Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
[TBL] [Abstract][Full Text] [Related]
18. Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drug.
Katcher ML; Reed CE
J Allergy Clin Immunol; 1980 Sep; 66(3):223-6. PubMed ID: 7410746
[TBL] [Abstract][Full Text] [Related]
19. Evidence for enhanced treatment of periodontal disease by therapy with coenzyme Q.
Matsumura T; Saji S; Nakamura R; Folkers K
Int J Vitam Nutr Res; 1973 Apr; 43(4):537-48. PubMed ID: 4588762
[No Abstract] [Full Text] [Related]
20. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
